The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hollander David since 2024.
This trader's CIK number is 1793796.
At the time of last reporting, Hollander David was the CMO & Global Therapeutics Lead of Revance Therapeutics, Inc.. (stock ticker symbol RVNC).
Also see all insider trading activities at Revance Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | RVNC | 0 | $0 | 3,908 | $16,296 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-11-18 | RVNC | Sale | 3,908 | 4.17 | 16,296 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hollander David (CMO & Global Therapeutics Lead of Revance Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.